Bank of New York Mellon’s Zentalis Pharmaceuticals ZNTL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-156,115
| Closed | -$248K | – | 4260 |
|
|
2025
Q1 | $248K | Sell |
156,115
-6,820
| -4% | -$10.8K | ﹤0.01% | 3763 |
|
|
2024
Q4 | $494K | Sell |
162,935
-10,375
| -6% | -$31.4K | ﹤0.01% | 3517 |
|
|
2024
Q3 | $638K | Sell |
173,310
-160,409
| -48% | -$590K | ﹤0.01% | 3368 |
|
|
2024
Q2 | $1.36M | Buy |
333,719
+43,839
| +15% | +$179K | ﹤0.01% | 3009 |
|
|
2024
Q1 | $4.57M | Sell |
289,880
-256
| -0.1% | -$4.04K | ﹤0.01% | 2367 |
|
|
2023
Q4 | $4.4M | Buy |
290,136
+48,027
| +20% | +$728K | ﹤0.01% | 2437 |
|
|
2023
Q3 | $4.86M | Buy |
242,109
+77,572
| +47% | +$1.56M | ﹤0.01% | 2331 |
|
|
2023
Q2 | $4.64M | Buy |
164,537
+8,985
| +6% | +$253K | ﹤0.01% | 2365 |
|
|
2023
Q1 | $2.68M | Sell |
155,552
-2,633
| -2% | -$45.3K | ﹤0.01% | 2627 |
|
|
2022
Q4 | $3.19M | Buy |
158,185
+5,377
| +4% | +$108K | ﹤0.01% | 2590 |
|
|
2022
Q3 | $3.31M | Buy |
152,808
+34,429
| +29% | +$746K | ﹤0.01% | 2526 |
|
|
2022
Q2 | $3.33M | Sell |
118,379
-25,224
| -18% | -$709K | ﹤0.01% | 2544 |
|
|
2022
Q1 | $6.63M | Sell |
143,603
-25
| -0% | -$1.15K | ﹤0.01% | 2278 |
|
|
2021
Q4 | $12.1M | Buy |
143,628
+5,001
| +4% | +$420K | ﹤0.01% | 2000 |
|
|
2021
Q3 | $9.24M | Buy |
138,627
+43,779
| +46% | +$2.92M | ﹤0.01% | 2165 |
|
|
2021
Q2 | $5.05M | Buy |
94,848
+5,047
| +6% | +$269K | ﹤0.01% | 2476 |
|
|
2021
Q1 | $3.9M | Sell |
89,801
-6,821
| -7% | -$296K | ﹤0.01% | 2562 |
|
|
2020
Q4 | $5.02M | Buy |
96,622
+63,303
| +190% | +$3.29M | ﹤0.01% | 2351 |
|
|
2020
Q3 | $1.09M | Buy |
33,319
+2,157
| +7% | +$70.6K | ﹤0.01% | 3078 |
|
|
2020
Q2 | $1.5M | Buy |
+31,162
| New | +$1.5M | ﹤0.01% | 2856 |
|